VOL.77/2024.12

Celltrionism

 

2021.02.08

 

 

 

 

 

 

 

 

 

 

 

 

Celltrion is a leading biotechnology company in Korea and the world. On the barren land of the pharmaceutical industry, Celltrion has successfully pioneered a new industry called “Antibody Biosimilars“ for the first time in the world. From its birth, to challenges, struggles, transformations, and growth.

Walk in the footsteps of Celltrion

“Celltrion has successfully developed biosimilars which the world deemed to be impossible. It dared to take on the challenge and prevailed.” -10p

“Celltrion will be the most extraordinary and bizarre company ever since Dangun, legendary founding father of Gojoseon.” -12p

 

With sales exceeding 2 trillion won, and market capitalization of 57 trillion won, Celltrion is a young company with an average age of 31.8. Celltrion has risen to turn the tables in the global biopharmaceutical industry! Learn the secret behind the “special achievement” attained by an “ordinary fringe group.”

 

First mover -How different does Celltrion work?

Celltrionism: How Celltrion Works
(Jun Ye-Jin, Dec. 2020, SmartBooks Inc.)

 

 

---